Personal Care
Health
Manufacturing

Johnson & Johnson

$132.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (0.18%) As of 3:11 PM EDT today
+$0.24 (0.18%) Today

Why Robinhood?

You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees
135,100
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
350.17B
Price-Earnings Ratio
21.86
Dividend Yield
2.78
Average Volume
7.84M
High Today
$132.50
Low Today
$131.17
Open Price
$132.12
Volume
3.95M
52 Week High
$148.99
52 Week Low
$121.00

Collections

Personal Care
Health
Manufacturing
Retail
Healthcare
Packaging
US
North America

JNJ News

BloombergJul 16

J&J Ups Sales Forecast as Cancer Drugs Drive Growth

96
Yahoo FinanceJul 16

What Q2 Johnson & Johnson earnings display about the company's future

2
BenzingaJul 16

United States Skincare Markets 2019-2023 with Estee Lauder Companies, Johnson & Johnson, L'Oreal and Procter & Gamble Dominating

205

JNJ Earnings

$1.72
$2.01
$2.29
$2.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$2.43 per share
Actual
$2.58 per share

Popular Stocks

More JNJ News

Wall Street JournalJul 16

Johnson & Johnson Bumps Up Sales Target

2
Barron'sJul 16

The Dow Is Slightly Lower Because Nothing Can Lift Stocks Today

478
CNBCJul 16

J&J vows to defend itself in talc, opioid lawsuits

264
Yahoo FinanceJul 16

Johnson & Johnson sees strong results in consumer, pharmaceutical ops

108
Yahoo FinanceJul 16

MARKETS: Goldman breaking out after earnings; J&J drops

345
MarketWatchJul 16

Stocks pull back from record levels as earnings season picks up steam

436
Barron'sJul 16

Johnson & Johnson’s Earnings Beat Estimates, but the Stock Isn’t Taking Off

319
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.